Article Details
Retrieved on: 2022-10-18 11:31:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Mereo BioPharma (MREO) will eliminate 40% of its workforce and embark on other cost-cutting measures in a move to extend its cash runway to 2026.
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here